company background image
DEMG

Deltex Medical GroupAIM:DEMG Stock Report

Market Cap

UK£8.9m

7D

-1.6%

1Y

15.1%

Updated

30 Nov, 2021

Data

Company Financials +
DEMG fundamental analysis
Snowflake Score
Valuation0/6
Future Growth1/6
Past Performance0/6
Financial Health6/6
Dividends0/6

DEMG Stock Overview

Deltex Medical Group plc, together with its subsidiaries, manufactures, markets, and sells oesophageal doppler haemodynamic monitoring systems under the TrueVue name in the United Kingdom, the United States, Spain, Canada, and internationally.

Price History & Performance

Summary of all time highs, changes and price drops for Deltex Medical Group
Historical stock prices
Current Share PriceUK£0.015
52 Week HighUK£0.023
52 Week LowUK£0.01
Beta0.54
1 Month Change-1.61%
3 Month Change-12.86%
1 Year Change15.09%
3 Year Change41.86%
5 Year Change-57.93%
Change since IPO-94.83%

Recent News & Updates

Sep 22
Deltex Medical Group (LON:DEMG) Is Making Moderate Use Of Debt

Deltex Medical Group (LON:DEMG) Is Making Moderate Use Of Debt

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Apr 29
Does Deltex Medical Group (LON:DEMG) Have A Healthy Balance Sheet?

Does Deltex Medical Group (LON:DEMG) Have A Healthy Balance Sheet?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Shareholder Returns

DEMGGB Medical EquipmentGB Market
7D-1.6%-4.1%-2.6%
1Y15.1%-12.2%10.9%

Return vs Industry: DEMG exceeded the UK Medical Equipment industry which returned -8.7% over the past year.

Return vs Market: DEMG exceeded the UK Market which returned 13.8% over the past year.

Price Volatility

Is DEMG's price volatile compared to industry and market?
DEMG volatility
DEMG Average Weekly Movement5.1%
Medical Equipment Industry Average Movement5.1%
Market Average Movement4.9%
10% most volatile stocks in GB Market9.8%
10% least volatile stocks in GB Market2.5%

Stable Share Price: DEMG is not significantly more volatile than the rest of UK stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: DEMG's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
200050Andy Mearshttps://www.deltexmedical.com

Deltex Medical Group plc, together with its subsidiaries, manufactures, markets, and sells oesophageal doppler haemodynamic monitoring systems under the TrueVue name in the United Kingdom, the United States, Spain, Canada, and internationally. It offers esophageal Doppler Probes that is used to measure a patient’s central vascular blood flow and fluid status to measure real time blood velocities within the descending aorta; Loops plots aortic blood flow velocity and aortic blood pressure monitoring throughout every heartbeat; High Definition Impedance Cardiography, a non-invasive cardiac function and fluid status monitoring system for awake patients; and PressureWave, a pulse pressure waveform analysis algorithm used during periods of instability or for periods when the ODM mode is unavailable. The company also provides Deltex Medical Esophageal Doppler Simulator that enables clinicians to practice probe insertion, focusing, and waveform interpretation outside of a patient setting.

Deltex Medical Group Fundamentals Summary

How do Deltex Medical Group's earnings and revenue compare to its market cap?
DEMG fundamental statistics
Market CapUK£8.92m
Earnings (TTM)-UK£735.00k
Revenue (TTM)UK£2.31m

3.9x

P/S Ratio

-12.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
DEMG income statement (TTM)
RevenueUK£2.31m
Cost of RevenueUK£737.00k
Gross ProfitUK£1.58m
ExpensesUK£2.31m
Earnings-UK£735.00k

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)-0.0013
Gross Margin68.14%
Net Profit Margin-31.78%
Debt/Equity Ratio54.6%

How did DEMG perform over the long term?

See historical performance and comparison

Valuation

Is Deltex Medical Group undervalued compared to its fair value and its price relative to the market?

3.93x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate DEMG's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate DEMG's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: DEMG is unprofitable, so we can't compare its PE Ratio to the UK Medical Equipment industry average.

PE vs Market: DEMG is unprofitable, so we can't compare its PE Ratio to the UK market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate DEMG's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: DEMG is overvalued based on its PB Ratio (3.9x) compared to the GB Medical Equipment industry average (3.5x).


Future Growth

How is Deltex Medical Group forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

19.5%

Forecasted annual revenue growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if DEMG's forecast earnings growth is above the savings rate (0.9%).

Earnings vs Market: Insufficient data to determine if DEMG's earnings are forecast to grow faster than the UK market

High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: DEMG's revenue (19.5% per year) is forecast to grow faster than the UK market (4.9% per year).

High Growth Revenue: DEMG's revenue (19.5% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if DEMG's Return on Equity is forecast to be high in 3 years time


Past Performance

How has Deltex Medical Group performed over the past 5 years?

37.2%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: DEMG is currently unprofitable.

Growing Profit Margin: DEMG is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: DEMG is unprofitable, but has reduced losses over the past 5 years at a rate of 37.2% per year.

Accelerating Growth: Unable to compare DEMG's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: DEMG is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (97.5%).


Return on Equity

High ROE: DEMG has a negative Return on Equity (-34.19%), as it is currently unprofitable.


Financial Health

How is Deltex Medical Group's financial position?


Financial Position Analysis

Short Term Liabilities: DEMG's short term assets (£2.0M) exceed its short term liabilities (£1.7M).

Long Term Liabilities: DEMG's short term assets (£2.0M) exceed its long term liabilities (£1.3M).


Debt to Equity History and Analysis

Debt Level: DEMG's net debt to equity ratio (28.8%) is considered satisfactory.

Reducing Debt: DEMG's debt to equity ratio has reduced from 61.5% to 54.6% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: DEMG has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: DEMG has sufficient cash runway for 1.8 years if free cash flow continues to grow at historical rates of 39.7% each year.


Dividend

What is Deltex Medical Group current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate DEMG's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate DEMG's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if DEMG's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if DEMG's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of DEMG's dividend in 3 years as they are not forecast to pay a notable one for the UK market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.4yrs

Average management tenure


CEO

Andy Mears (52 yo)

3.42yrs

Tenure

UK£219,210

Compensation

Mr. Andrew Jonathan Mears, also known as Andy, has been Chief Executive Officer and Director of Deltex Medical Group plc since June 13, 2018. Mr. Mears was Managing Director of Deltex Medical Group plc sin...


CEO Compensation Analysis

Compensation vs Market: Andy's total compensation ($USD290.25K) is about average for companies of similar size in the UK market ($USD324.53K).

Compensation vs Earnings: Andy's compensation has increased whilst the company is unprofitable.


Leadership Team

Experienced Management: DEMG's management team is considered experienced (3.4 years average tenure).


Board Members

Experienced Board: DEMG's board of directors are considered experienced (6.4 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 11.4%.


Top Shareholders

Company Information

Deltex Medical Group plc's employee growth, exchange listings and data sources


Key Information

  • Name: Deltex Medical Group plc
  • Ticker: DEMG
  • Exchange: AIM
  • Founded: 2000
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: UK£8.920m
  • Shares outstanding: 584.94m
  • Website: https://www.deltexmedical.com

Number of Employees


Location

  • Deltex Medical Group plc
  • Terminus Road
  • West Sussex
  • Chichester
  • West Sussex
  • PO19 8TX
  • United Kingdom

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/11/30 21:33
End of Day Share Price2021/11/30 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.